Broncotron-D Interactions
There are 517 drugs known to interact with Broncotron-D (dextromethorphan/guaifenesin/phenylephrine), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 87 are major, 427 are moderate, and 3 are minor.
- View all 517 medications that may interact with Broncotron-D
- View Broncotron-D alcohol/food interactions (1)
- View Broncotron-D disease interactions (4)
Most frequently checked interactions
View interaction reports for Broncotron-D (dextromethorphan / guaifenesin / phenylephrine) and the medicines listed below.
- acetylcysteine
- acyclovir
- albuterol
- alprazolam
- amoxicillin
- Atarax (hydroxyzine)
- betamethasone topical
- Brometane DX (brompheniramine / dextromethorphan / pseudoephedrine)
- carbetapentane
- celecoxib
- cetirizine
- Children's Claritin Allergy (loratadine)
- Children's Tylenol (acetaminophen)
- chlorpheniramine
- Chlorpheniramine (Allergy) (chlorpheniramine)
- clarithromycin
- Cloderm (clocortolone topical)
- clotrimazole topical
- Concerta (methylphenidate)
- cromolyn
- desloratadine
- dexchlorpheniramine
- diclofenac
- dyphylline
- escitalopram
- esomeprazole
- ezetimibe
- fexofenadine
- finasteride
- prednisolone
Broncotron-D alcohol/food interactions
There is 1 alcohol/food interaction with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine).
Broncotron-D disease interactions
There are 4 disease interactions with Broncotron-D (dextromethorphan / guaifenesin / phenylephrine) which include:
Report options
More about Broncotron-D (dextromethorphan / guaifenesin / phenylephrine)
- Broncotron-D consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.